Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
16,89 USD | +0,30% | +1,93% | +19,62% |
Omzet 2024 * | 167 mln. 155 mln. | Omzet 2025 * | 301 mln. 279 mln. | Marktkapitalisatie | 1,53 mld. 1,42 mld. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | -33 mln. -30,59 mln. | Nettowinst (verlies) 2025 * | 91 mln. 84,35 mln. | EV/omzet 2024 * | 9,55 x |
Nettoschuld 2024 * | 66,33 mln. 61,48 mln. | Nettoliquiditeiten 2025 * | 5,71 mln. 5,3 mln. | EV/omzet 2025 * | 5,07 x |
K/w-verhouding 2024 * |
-37,4
x | K/w-verhouding 2025 * |
21,2
x | Werknemers | 154 |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 39,35% |
Recentste transcriptie over Avadel Pharmaceuticals plc
1 dag | +0,30% | ||
1 week | +1,93% | ||
Lopende maand | +32,16% | ||
1 maand | +26,90% | ||
3 maanden | +17,29% | ||
6 maanden | +57,26% | ||
Lopend jaar | +19,62% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Gregory Divis
CEO | Chief Executive Officer | 57 | 03-01-17 |
Thomas McHugh
DFI | Director of Finance/CFO | 59 | 02-12-19 |
Scott Macke
COO | Chief Operating Officer | - | 01-09-14 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Eric Ende
BRD | Director/Board Member | 55 | 01-12-18 |
Gregory Divis
CEO | Chief Executive Officer | 57 | 03-01-17 |
Mark McCamish
BRD | Director/Board Member | 72 | 05-12-19 |
Datum | Koers | Variatie | Volume |
---|---|---|---|
28-03-24 | 16,89 | +0,30% | 510 834 |
27-03-24 | 16,84 | +3,69% | 355 913 |
26-03-24 | 16,24 | -2,11% | 463 601 |
25-03-24 | 16,59 | -3,66% | 783 230 |
22-03-24 | 17,22 | +0,76% | 917 945 |
uitgestelde koers Nasdaq, 28 maart 2024 om 21:30 uur
Meer koersenHerzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
+19,62% | 1,53 mld. | |
+33,46% | 701 mld. | |
+26,24% | 571 mld. | |
+0,93% | 381 mld. | |
+21,03% | 334 mld. | |
+17,51% | 319 mld. | |
+0,74% | 210 mld. | |
+2,95% | 210 mld. | |
-6,05% | 201 mld. | |
-3,61% | 157 mld. |